Type 1 diabetes affects millions of people globally and requires careful management to
avoid serious long-term complications, including heart and kidney disease, stroke, and loss …

This article describes the epidemiology of type 1 diabetes mellitus (T1D) around the world
and across the lifespan. Epidemiologic patterns of T1D by demographic, geographic …

Objective To assess the risk of new-onset type 1 diabetes mellitus (T1D) diagnosis following
COVID-19 diagnosis and the impact of COVID-19 diagnosis on the risk of diabetic …

In recent years, immune checkpoint inhibitors have emerged as effective therapies for
advanced neoplasias. As new checkpoint target blockers become available and additional …

T‐cell immunotherapy offers outstanding advantages in the treatment of various diseases,
and with the selection of appropriate targets, efficient disease treatment can be achieved. T …

The incidence of youth type 2 diabetes (T2D), linked with obesity and declining physical
activity in high‐risk populations, is increasing. Recent multicenter studies have led to a …

Genome-wide association studies provide insight into multigenic diseases through the
identification of susceptibility genes and etiological pathways. In addition, the identification …

Type 1 diabetes (T1D) is an autoimmune disease mediated by a combination of genetic and
environmental triggers resulting in lymphocytic infiltration of pancreatic islets, destruction of …

Abstract Type 1 diabetes (T1D) is mediated by destruction of pancreatic β cells by
autoantigen-specific CD4+ and CD8+ T cells, thus the ideal solution for T1D is the …

Latent autoimmune diabetes in adults (LADA) is characterized by the presence of islet
autoantibodies and initial insulin independence, which can lead to misdiagnosis of type 2 …